Dog /
2026 FDA CVM data 1,124 reports on file official source

Spitz - American Eskimo Dog — FDA Adverse Event Profile

Adverse-event records and label data for Spitz - American Eskimo Dog (Dog), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.

Verify with FDA CVM →
Annual breed adverse-event registration timeline Bar chart showing yearly FDA Center for Veterinary Medicine adverse event report counts per breed registry cohort, with paw-print tick marks indicating count buckets. 82 61.5 41 20.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Spitz - American Eskimo Dog drawn from FDA CVM filings.

Spitz - American Eskimo Dog (Dog) has 1,124 FDA adverse event reports on record, with 52 deaths reported (460.0% death rate) — ranking #105 by report volume. The most frequently reported reaction is Vomiting (274 cases). The top associated drug is Milbemycin Oxime + Spinosad. Average age at report: 7.2 years.

Total Reports

1,124

FDA CVM filings

Deaths Reported

52

of 1,124 reports

Death Rate

460.0%

death-coded share

Avg Age at Report

7.2 yr

11.6 kg avg weight

Death-Coded Outcome Share

Spitz - American Eskimo Dog death-coded reports 100.0%
Database median

460.0% of 1,124 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 11.6 kg (25.6 lbs)

Top Reported Reactions

Vomiting 274
Lethargy (see also Central nervous system depression in 'Neurological') 118
Diarrhoea 101
Emesis 101
Lack of efficacy (ectoparasite) - flea 74
Seizure NOS 68
Lack of efficacy - NOS 51
Lack of efficacy (endoparasite) - hookworm 47
Anorexia 47
Digestive tract disorder NOS 38
Behavioural disorder NOS 35
INEFFECTIVE, HEARTWORM LARVAE 31
Elevated blood urea nitrogen (BUN) 29
Ataxia 27
Emesis (multiple) 25

Most Referenced Drugs

Milbemycin Oxime + Spinosad 192
Spinosad 96
Afoxolaner 89
Ivermectin + Pyrantel As Pamoate Salt 83
Fluralaner Chew Tablets 53
Trilostane 45
Moxidectin 39
Carprofen 33
Sarolaner 33
Pyrantel Pamoate;Sarolaner 33
Milbemycin Oxime + Praziquantel 31
Fluralaner 13.64% 12-Week Chew 27
Bedinvetmab 22
Selamectin 21
Imidacloprid + Moxidectin 17

Outcome Breakdown

Recovered/Normal
389 (38.4%)
Outcome Unknown
328 (32.3%)
Ongoing
200 (19.7%)
Recovered with Sequela
45 (4.4%)
Died
26 (2.6%)
Euthanized
26 (2.6%)

Gender Distribution

Male 557 (49.6%)
Female 549 (48.8%)
Unknown 16 (1.4%)
Mixed 2 (0.2%)

Reports by Year

Year Reports Trend
2010 66
2011 74
2012 91
2013 97
2014 93
2015 95
2016 80
2017 78
2018 69
2019 82
2020 78
2021 54
2022 35
2023 43
2024 59
2025 30
Size-class weight distribution across registered breeds Vertical bar chart showing the distribution of registered breeds across five size classes (Toy, Small, Medium, Large, Giant), each represented by a scaled dog-silhouette and a count value. 118 89 59 30 0 Breeds in class 38 Toy 0–6 kg Chihuahua 64 Small 6–14 kg Beagle 92 Medium 14–27 kg Border Collie 118 Large 27–45 kg Labrador Retriever 41 Giant 45–90 kg Great Dane Size-Class Distribution
Where Spitz - American Eskimo Dog sits in the registered size-class taxonomy. Average reported weight: 11.6 kg.
Breed-group distribution donut chart Donut chart with kennel-club-ribbon center showing breed counts across the eight standard breed groups (Sporting, Hound, Working, Terrier, Toy, Non-Sporting, Herding, Miscellaneous). CH Sporting 32 · 14.2% Hound 36 · 15.9% Working 33 · 14.6% Terrier 31 · 13.7% Toy 23 · 10.2% Non-Sporting 21 · 9.3% Herding 32 · 14.2% Misc. 18 · 8.0% Breed-Group Classification 226 breeds across 8 taxonomic groups
Eight standard breed-group classifications used by major registries (AKC's seven groups plus Miscellaneous). Provides taxonomic context for breed lookups.

Spitz - American Eskimo Dog Pet Health Insights

Across the FDA Center for Veterinary Medicine adverse event database, Spitz - American Eskimo Dog accounts for 1,124 submitted reports and currently ranks #105 by report volume within the dog population. Of those reports, 52 involved a death outcome — a 460.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 7.2 years, with an average recorded body weight of 11.6 kg (25.6 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.

The most frequently reported clinical signs for Spitz - American Eskimo Dog are Vomiting (274 reports), Lethargy (see also Central nervous system depression in 'Neurological') (118 reports), Diarrhoea (101 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Milbemycin Oxime + Spinosad appears in 192 reports and is the single most-referenced drug, followed by Spinosad (96) and Afoxolaner (89). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same dog species.

Outcome coding on the 1,014 reports with a recorded status is dominated by Recovered/Normal (38.4% of coded outcomes). Annual submission volume ranges from 2,010 to 2,025 reports across the 16 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual dog.

Understanding Spitz - American Eskimo Dog Adverse Event Data

Spitz - American Eskimo Dog has a moderate volume of adverse event reports (1,124). Report counts are influenced by breed popularity, owner awareness, and veterinary reporting practices.

The 460.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.

The most frequently referenced drug in adverse reports is Milbemycin Oxime + Spinosad, appearing in 192 reports. This may indicate widespread use of the medication rather than a specific safety concern for Spitz - American Eskimo Dog.

Other Dog Breeds

Frequently Asked Questions

How many FDA adverse event reports involve Spitz - American Eskimo Dog?
There are 1,124 adverse event reports involving Spitz - American Eskimo Dog in the FDA database, with 52 reports involving death (460.0% death rate). Spitz - American Eskimo Dog ranks #105 by report volume.
What are the most common adverse reactions reported for Spitz - American Eskimo Dog?
The most commonly reported adverse reactions for Spitz - American Eskimo Dog are Vomiting (274 reports), Lethargy (see also Central nervous system depression in 'Neurological') (118 reports), Diarrhoea (101 reports), Emesis (101 reports), Lack of efficacy (ectoparasite) - flea (74 reports).
What drugs are most frequently associated with Spitz - American Eskimo Dog adverse events?
The drugs most frequently referenced in Spitz - American Eskimo Dog adverse event reports are Milbemycin Oxime + Spinosad (192 reports), Spinosad (96 reports), Afoxolaner (89 reports), Ivermectin + Pyrantel As Pamoate Salt (83 reports), Fluralaner Chew Tablets (53 reports).
What is the average age of Spitz - American Eskimo Dog in adverse event reports?
The average age of Spitz - American Eskimo Dog at the time of adverse event reports is 7.2 years, with an average weight of 11.6 kg (25.6 lbs).
Does a high number of adverse event reports mean Spitz - American Eskimo Dog is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spitz - American Eskimo Dog safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Guides & Resources

Related Data Sources

Data Sources & Methodology

Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.

Spitz - American Eskimo Dog ranks #105 by total report volume. Death rate (460.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial